{"id":"https://openalex.org/W54594590","doi":null,"title":"Monoclonal antibody-based immunotherapy of Hodgkin's lymphoma.","display_name":"Monoclonal antibody-based immunotherapy of Hodgkin's lymphoma.","publication_year":2004,"publication_date":"2004-12-01","ids":{"openalex":"https://openalex.org/W54594590","mag":"54594590","pmid":"https://pubmed.ncbi.nlm.nih.gov/15648946"},"language":"en","primary_location":{"id":"pmid:15648946","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15648946","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064132655","display_name":"Peter Borchmann","orcid":"https://orcid.org/0000-0003-3782-2158","observed_orcids":["https://orcid.org/0000-0003-3782-2158"]},"institutions":[{"id":"https://openalex.org/I180923762","display_name":"University of Cologne","ror":"https://ror.org/00rcxh774","country_code":"DE","type":"education","lineage":["https://openalex.org/I180923762"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Peter Borchmann","raw_affiliation_strings":["Klinik I f\u00fcr Innere Medizin, Universit\u00e4t zu K\u00f6ln, Joseph-Stelzmann-Strasse 9, D-50924 K\u00f6ln, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinik I f\u00fcr Innere Medizin, Universit\u00e4t zu K\u00f6ln, Joseph-Stelzmann-Strasse 9, D-50924 K\u00f6ln, Germany","institution_ids":["https://openalex.org/I180923762"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108642275","display_name":"Roland Schnell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roland Schnell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036810185","display_name":"H. Schulz","orcid":"https://orcid.org/0000-0003-3428-8922","observed_orcids":["https://orcid.org/0000-0003-3428-8922"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Holger Schulz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5071228709","display_name":"Andreas Engert","orcid":"https://orcid.org/0000-0001-6611-6979","observed_orcids":["https://orcid.org/0000-0001-6611-6979"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas Engert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9997,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.7685402,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"5","issue":"12","first_page":"1262","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00839999970048666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hodgkin-lymphoma","display_name":"Hodgkin's disease","score":0.9890000224113464},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9660000205039978},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.7829999923706055},{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.9240000247955322},{"id":"https://openalex.org/keywords/immunotoxins","display_name":"immunotoxins","score":0.8960000276565552},{"id":"https://openalex.org/keywords/bispecific-molecules","display_name":"bispecific molecules","score":0.8619999885559082},{"id":"https://openalex.org/keywords/anti-cd30-antibody","display_name":"anti-CD30 antibody","score":0.800000011920929},{"id":"https://openalex.org/keywords/humanized-antibody","display_name":"humanized monoclonal antibody","score":0.6169999837875366},{"id":"https://openalex.org/keywords/reed-sternberg-cells","display_name":"Reed-Sternberg cells","score":0.8700000047683716},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.699999988079071},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6259999871253967},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.8304044008255005},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7539124488830566},{"id":"https://openalex.org/C115085202","wikidata":"https://www.wikidata.org/wiki/Q425665","display_name":"Immunotoxin","level":4,"score":0.6751899123191833},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6383472681045532},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6233108043670654},{"id":"https://openalex.org/C2778191690","wikidata":"https://www.wikidata.org/wiki/Q422324","display_name":"Brentuximab vedotin","level":4,"score":0.5875535011291504},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5794501304626465},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5666223764419556},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.517941415309906},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.45736628770828247},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4511328637599945},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38849613070487976},{"id":"https://openalex.org/C70905583","wikidata":"https://www.wikidata.org/wiki/Q3648608","display_name":"CD30","level":3,"score":0.3689693212509155},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3629714250564575},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2078888714313507},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13467609882354736},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006689","descriptor_name":"Hodgkin Disease","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006689","descriptor_name":"Hodgkin Disease","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016233","descriptor_name":"Immunotherapy, Active","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15648946","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15648946","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},{"id":"mag:54594590","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15648946","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1700254622","https://openalex.org/W2049644841","https://openalex.org/W3094350611","https://openalex.org/W2416231044","https://openalex.org/W1975716255","https://openalex.org/W4317754082","https://openalex.org/W2112059762","https://openalex.org/W2056822300","https://openalex.org/W2061945452","https://openalex.org/W1744109090"],"abstract_inverted_index":{"Many":[0],"new":[1],"approaches":[2,49],"involving":[3],"the":[4,142,147,178],"use":[5],"of":[6,68,152,156,180],"antibody-based":[7],"agents":[8],"have":[9,32],"produced":[10],"promising":[11,172],"results":[12],"in":[13,37,99,133],"experimental":[14],"Hodgkin's":[15],"lymphoma":[16],"(HL)":[17],"models.":[18],"Early":[19],"clinical":[20,35,136],"trials":[21],"using":[22,112],"immunotoxins,":[23],"radioimmunotherapy":[24],"(RIT),":[25],"bispecific":[26],"molecules":[27],"and":[28,108,123,149,169],"monoclonal":[29],"antibodies":[30],"(mAbs),":[31],"demonstrated":[33],"some":[34],"efficacy":[36,98],"patients":[38,54],"with":[39,55,60,166],"advanced":[40],"refractory":[41,100],"HL.":[42,181],"Although":[43],"it":[44],"seems":[45],"unlikely":[46],"that":[47],"these":[48,161],"alone":[50],"will":[51],"cure":[52],"chemotherapy-resistant":[53],"larger":[56],"tumor":[57],"masses,":[58],"combination":[59],"conventional":[61,167],"chemotherapy":[62,168],"may":[63,86],"help":[64],"to":[65,73,83,118],"overcome":[66],"resistance":[67],"Hodgkin-Reed/Sternberg":[69],"(H-RS)":[70],"cells":[71,79],"or":[72,115],"eliminate":[74],"residual":[75],"disease.":[76],"Since":[77],"H-RS":[78,157],"are":[80,129,150,170],"extremely":[81],"sensitive":[82],"irradiation,":[84],"RIT":[85],"be":[87,119,164],"a":[88,106,124],"potential":[89],"approach.":[90],"A":[91,121],"murine":[92],"mAb":[93,128],"(Ki-4)-based":[94],"131I":[95],"conjugate":[96],"showed":[97],"HL":[101,148],"patients,":[102],"however,":[103],"toxicity":[104],"was":[105],"problem":[107],"less":[109],"toxic":[110],"constructs":[111],"alternate":[113],"mAbs":[114,139,162],"isotopes":[116],"need":[117],"designed.":[120],"humanized":[122],"fully":[125],"human":[126,143],"anti-CD30":[127],"currently":[130],"being":[131],"evaluated":[132],"phase":[134],"I/II":[135],"trials.":[137],"These":[138],"could":[140,163],"engage":[141],"immune":[144],"system":[145],"against":[146],"capable":[151],"directly":[153],"inducing":[154],"apoptosis":[155],"cells.":[158],"In":[159],"addition,":[160],"combined":[165],"thus":[171],"candidates":[173],"for":[174,177],"further":[175],"development":[176],"therapy":[179]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}